ATHX
ATHERSYS INC NEWstockOTC
InactiveJan 8, 2024
0.0135USD-33.498%(-0.0068)6,462,682
Loading…
Loading…
Sector
Healthcare
Industry
Biotechnology
CEO
Gil Van Bokkelen
HQ
Cleveland, Ohio, USA
Aug 29, 2022 · 1-for-25 (reverse)
ATHX Profile
athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. we are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. this pipeline includes both stem cell therapy and pharmaceuticals.
ATHX Performance
| Period | Price | Date | Change |
|---|
